Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2025-08-11 00:00:00 ET · period of report 2025-08-07 · accession 0001765581-25-000082 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-08-11 | 2025-08-07 | JAZZ | RIEDEL NORBERT G | Dir | A - Grant | $0.00 | +3,507 | 8,829 | +66% | $0 | |
| 2025-08-11 | 2025-08-08 | JAZZ | RIEDEL NORBERT G | Dir | F - Tax | $111.25 | -1,805 | 7,024 | -20% | -$200.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-08-07 | A | A | 3,507 | $0.00 | 8,829 | D | — | — | |
| 2 | Common | Ordinary Shares | 2025-08-08 | F | D | 1,805 | $111.25 | 7,024 | D | — | — | (F3) Shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST, an entity owned and controlled by the reporting person and his immediate family. |